Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyburide vs Metformin in Gestational Diabetes (GLAM)
NCT03078725Phase 4Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Jun 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of glibenclamide, liquid metformin (Aspargo Labs) in gestational diabetes mellitus (GDM), sponsored by UTHealth Houston. Planned start Jun 2017; status: withdrawn.
02
Drugs
glibenclamideliquid metformin (Aspargo Labs)
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT03078725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078725.